Documents

Displaying 1 - 13 of 13 results
 
Collapse Filters
 
Expand Filters         +
August 13, 2018

Latent Print Examination Manual

Drug Enforcement Administration Office of Forensic Sciences Latent Print Examination Manual July 2018

March 30, 2018

Summary of Validated Methods

This document is an internal Drug Enforcement Administration quality system document.  The document is updated periodically and current as of March 30, 2018 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some documents in their entirety. All redactions are clearly present in this document. Names of commercial manufacturers are provided for identification only, and inclusion does not imply endorsement by the Drug Enforcement Administration.

March 30, 2018

Chapter 79: Security

This document is an internal Drug Enforcement Administration quality system document.  The document is updated periodically and current as of March 30, 2018 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some documents in their entirety. All redactions are clearly present in this document. Names of commercial manufacturers are provided for identification only, and inclusion does not imply endorsement by the Drug Enforcement Administration.

March 30, 2018

Chapter 78: Hazardous Waste and Chemical Storage

This document is an internal Drug Enforcement Administration quality system document.  The document is updated periodically and current as of March 30, 2018 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some documents in their entirety. All redactions are clearly present in this document. Names of commercial manufacturers are provided for identification only, and inclusion does not imply endorsement by the Drug Enforcement Administration.

March 30, 2018

Chapter 77: Safety

This document is an internal Drug Enforcement Administration quality system document.  The document is updated periodically and current as of March 30, 2018 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some documents in their entirety. All redactions are clearly present in this document. Names of commercial manufacturers are provided for identification only, and inclusion does not imply endorsement by the Drug Enforcement Administration.

March 30, 2018

Chapter 76: Laboratory Special Studies

This document is an internal Drug Enforcement Administration quality system document.  The document is updated periodically and current as of March 30, 2018 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some documents in their entirety. All redactions are clearly present in this document. Names of commercial manufacturers are provided for identification only, and inclusion does not imply endorsement by the Drug Enforcement Administration.

March 30, 2018

Chapter 75: Laboratory Financial and Resource Management

This document is an internal Drug Enforcement Administration quality system document.  The document is updated periodically and current as of March 30, 2018 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some documents in their entirety. All redactions are clearly present in this document. Names of commercial manufacturers are provided for identification only, and inclusion does not imply endorsement by the Drug Enforcement Administration.

March 30, 2018

Chapter 74: Managing Laboratory Stockpiles and Special Programs

This document is an internal Drug Enforcement Administration quality system document.  The document is updated periodically and current as of March 30, 2018 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some documents in their entirety. All redactions are clearly present in this document. Names of commercial manufacturers are provided for identification only, and inclusion does not imply endorsement by the Drug Enforcement Administration.

March 30, 2018

Chapter 73: Managing Laboratory Evidence

This document is an internal Drug Enforcement Administration quality system document.  The document is updated periodically and current as of March 30, 2018 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some documents in their entirety. All redactions are clearly present in this document. Names of commercial manufacturers are provided for identification only, and inclusion does not imply endorsement by the Drug Enforcement Administration.

March 30, 2018

Chapter 72: Staffing, Training, and Personnel Actions

This document is an internal Drug Enforcement Administration quality system document.  The document is updated periodically and current as of March 30, 2018 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some documents in their entirety. All redactions are clearly present in this document. Names of commercial manufacturers are provided for identification only, and inclusion does not imply endorsement by the Drug Enforcement Administration.

March 30, 2018

Chapter 71: Quality Assurance

This document is an internal Drug Enforcement Administration quality system document.  The document is updated periodically and current as of March 30, 2018 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some documents in their entirety. All redactions are clearly present in this document. Names of commercial manufacturers are provided for identification only, and inclusion does not imply endorsement by the Drug Enforcement Administration.

March 30, 2018

Chapter 70: Laboratory Operations

This document is an internal Drug Enforcement Administration quality system document.  The document is updated periodically and current as of March 30, 2018 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some documents in their entirety. All redactions are clearly present in this document. Names of commercial manufacturers are provided for identification only, and inclusion does not imply endorsement by the Drug Enforcement Administration.

March 30, 2018

Analysis of Drugs Manual

This document is an internal Drug Enforcement Administration quality system document.  The document is updated periodically and current as of March 30, 2018 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some documents in their entirety. All redactions are clearly present in this document. Names of commercial manufacturers are provided for identification only, and inclusion does not imply endorsement by the Drug Enforcement Administration.

DEA US Badge
United States Drug Enforcement Administration DEA.gov is an official site of the U.S. Department of Justice